Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

CV ansehen CV ausblenden

Aktuelle News & Insights

Life Sciences & Healthcare

Advising leading-edge life sciences companies on transformational roll-up and $114m crossover financing

10. März 2021

von Ross McNaughton und Richard Faichney

Klicken Sie hier für Details
Life Sciences & Healthcare

Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies

16. Februar 2021

von Ross McNaughton und Colin McCall

Klicken Sie hier für Details
Technology, Media & Communications

Investment round for Cambridge quantum computing company

10. Februar 2021

von Ross McNaughton und Alex Dodds

Klicken Sie hier für Details
Technology, Media & Communications

Advising Oxbotica in $47 million Series B investment

15. Januar 2021

von Ross McNaughton und Matt Harrison

Klicken Sie hier für Details

Meet me at

Alle Veranstaltungen und Webinare finden Sie auf unserer Event-Seite.